PM360

NOVEMBER 21, 2022

When Marc’s doctors discovered he had a rare liver condition, it almost felt like a relief. Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medical science can achieve. At least his enemy now had a name. Piecing the Fragments Together.

Patients 52

Patients Medicine Biopharma Media 52

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Medgadget

MARCH 22, 2023

This is very difficult psychologically for the the patient (and doctor) to wait for a long time to obtain results and not start treatment, as the cancer can deteriorate while waiting. We hope to see Imagene showing off its technology at Biomed Israel , the leading international Life Science and HealthTech conference in Israel.

Patients 79

Patients Medical science Leads Medical 79